Atherosclerosis is widely considered a slowly progressing disease that mainly affects the elderly. Recent evidence however has demonstrated that plaques start to build up decades before patient hospitalization. Therefore, there is an unmet clinical need to further define the earliest molecular and phenotypic changes that occur during atherosclerosis to design more efficacious therapies.
The lab of Dr. Calum A. MacRae (MD, PhD) is therefore looking for a highly motivated postdoctoral research fellow to study the early molecular mechanisms driving atherogenesis, with an emphasis on endothelial dysfunction –an early hallmark of this progressive disease.
Skills & Experience
The successful candidate must demonstrate the ability to work independently and as a team, to think analytically and must display excellent skills in manuscript and grant writing. Experience with zebrafish or bio-informatics is desirable, but not essential. The position is available immediately.
Candidates will join our interdisciplinary team of clinicians and research fellows to find novel therapeutic avenues to treat atherogenesis and coronary artery disease using a unique combination of high resolution imaging in zebrafish, transcriptional profiling of distinct cell types and human genetics.
Brigham & Women’s Hospital(BWH) and Harvard Medical School
Applications from women and under-represented minorities are highly encouraged. The Brigham and Women’s Hospital and Harvard Medical School is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, genetic information, protected veteran or disabled status.
To apply, please send a cover letter that includes the names and contacts for three references and a short statement of research interests and a current CV.Apply To Job